Israel: "Pfizer Two-Dose Vaccination Provides 94% Prevention Effect"

[Image source=Reuters Yonhap News]

[Asia Economy Reporter Cho Hyun-ui] A study in Israel has found that Pfizer's COVID-19 vaccine is 94% effective.

On the 14th (local time), according to major foreign media, Clalit, Israel's largest health organization, reported this result after administering two doses to 600,000 people in the country. The probability of severe illness also decreased by 92%.

Clalit explained, "As in Pfizer's clinical trials, the vaccine's effectiveness became clearly evident one week after the second dose," adding, "From two weeks after, the effect was even stronger."

Israel, one of the world's fastest countries in vaccination speed, has so far administered the first dose to 3.8 million people, and 2.4 million have completed the second dose.

Israel, calling itself an 'immunity laboratory,' is sharing analysis results on vaccine effectiveness. The Weizmann Institute of Science in Israel, which is compiling domestic vaccination results, announced that "hospitalization rates and severe illness rates have sharply declined among those aged 60 and over, who were the first to be vaccinated."

This content was produced with the assistance of AI translation services.